38 articles for EW Yue
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology.

Incyte
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.

Incyte
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.

Bristol-Myers Squibb
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.

Bristol-Myers Squibb
Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.

Incyte
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.

Incyte
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.

Incyte
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ).

Incyte
NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE

Temple University
HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF

Voronoi
COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THE SAME

University of Arizona
Substituted 4-phenylpiperidines, their preparation and use

Columbia University
Immunomodulator compounds

Chemocentryx
Compound, compositions, and methods

Denali Therapeutics
Fused ring derivative having MGAT-2 inhibitory activity

Shionogi
Substituted heterocyclyl derivatives as CDK inhibitors

Aurigene Discovery Technologies
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides

Arvinas Operations
Cyanoindazole compounds and uses thereof

Incyte
IBAT inhibitors for the treatment of liver diseases

Albireo
Substituted indoles as modulators of ROR-gamma

Vitae Pharmaceuticals
Benzimidazole derivatives as EP4 antagonists

Bayer Pharma Aktiengesellschaft
Kinetic and in silico analysis of thiazolidin-based inhibitors of a-carbonic anhydrase isoenzymes.

Ondokuz Mayis University
Serine/threonine kinase inhibitors

Genetech
Hetarylcoumarins: Synthesis and biological evaluation as potent a-glucosidase inhibitors.

Kinnaird College For Women
New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.

Alexandria University
Antagonists of prostaglandin EP3 receptor

Pfizer
Amino-substituted imidazopyridazines

Bayer Pharma Aktiengesellschaft
Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.

Government College University
Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists

Sanofi
Substituted isoquinolinones and quinazolinones

Novartis
Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors

Astrazeneca
Oxadiazole inhibitors of leukotriene production

Boehringer Ingelheim International
Pharmacological characterization of KUR-1246, a selective uterine relaxant.

Kissei Pharmaceutical
Design and synthesis of conformationally constrained cyclophilin inhibitors showing a cyclosporin-A phenotype in C. elegans.

The University of Edinburgh
Heteroaryl substituted pyridyl compounds useful as kinase modulators

Bristol-Myers Squibb
DISCOVERY AND STRUCTURE-ACTIVITY STUDIES OF A NOVEL SERIES OF PYRIDO[2,3-d]PYRIMIDINE TYROSINE KINASE INHIBITORS

Parke-Davis Pharmaceutical Research
Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design.

Sunesis Pharmaceuticals